Clinical trials sponsored by ANRS, Emerging Infectious Diseases
8
Recruiting trials
13
Conditions studied
Phase breakdown
Phase 2 2Phase 3 2Phase 4 1Not applicable 3
Conditions studied
Recruiting trials led by ANRS, Emerging Infectious Diseases
- Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant Women
- Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.
- Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial
- Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
- National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses
- Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control
- Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
- the ANRS CO21 " Extreme " Cohort (CODEX)
Common questions
How many trials is ANRS, Emerging Infectious Diseases recruiting for?
ANRS, Emerging Infectious Diseases is the lead sponsor of 8 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.